Pharmacokinetics, efficacy and safety of daclatasvir plus asunaprevir in dialysis patients with chronic hepatitis <scp>C</scp>: pilot study
Pharmacokinetics, efficacy and safety of daclatasvir plus asunaprevir in dialysis patients with chronic hepatitis <scp>C</scp>: pilot study is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Pharmacokinetics, efficacy and safety of daclatasvir plus asunaprevir in dialysis patients with chronic hepatitis <scp>C</scp>: pilot study have?
Pharmacokinetics, efficacy and safety of daclatasvir plus asunaprevir in dialysis patients with chronic hepatitis <scp>C</scp>: pilot study has 39 citations in the OpenAlex counts ScholarIQ stores.
When was Pharmacokinetics, efficacy and safety of daclatasvir plus asunaprevir in dialysis patients with chronic hepatitis <scp>C</scp>: pilot study published?
Pharmacokinetics, efficacy and safety of daclatasvir plus asunaprevir in dialysis patients with chronic hepatitis <scp>C</scp>: pilot study has 2016 year in the ScholarIQ index.
What is the open-access status of Pharmacokinetics, efficacy and safety of daclatasvir plus asunaprevir in dialysis patients with chronic hepatitis <scp>C</scp>: pilot study?
Pharmacokinetics, efficacy and safety of daclatasvir plus asunaprevir in dialysis patients with chronic hepatitis <scp>C</scp>: pilot study has closed oa status in the ScholarIQ index.
What is the DOI of Pharmacokinetics, efficacy and safety of daclatasvir plus asunaprevir in dialysis patients with chronic hepatitis <scp>C</scp>: pilot study?
The DOI for Pharmacokinetics, efficacy and safety of daclatasvir plus asunaprevir in dialysis patients with chronic hepatitis <scp>C</scp>: pilot study is on the source record.
What is the PMID of Pharmacokinetics, efficacy and safety of daclatasvir plus asunaprevir in dialysis patients with chronic hepatitis <scp>C</scp>: pilot study?
The PMID for Pharmacokinetics, efficacy and safety of daclatasvir plus asunaprevir in dialysis patients with chronic hepatitis <scp>C</scp>: pilot study is on the source record.
What is the OpenAlex record for Pharmacokinetics, efficacy and safety of daclatasvir plus asunaprevir in dialysis patients with chronic hepatitis <scp>C</scp>: pilot study?
The OpenAlex for Pharmacokinetics, efficacy and safety of daclatasvir plus asunaprevir in dialysis patients with chronic hepatitis <scp>C</scp>: pilot study is on the source record.